Macquarie Group’s NextCure NXTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-12,500
| Closed | -$69K | – | 1666 |
|
|
2025
Q2 | $69K | Hold |
12,500
| – | – | ﹤0.01% | 1585 |
|
|
2025
Q1 | $72K | Hold |
12,500
| – | – | ﹤0.01% | 1561 |
|
|
2024
Q4 | $116K | Hold |
12,500
| – | – | ﹤0.01% | 1542 |
|
|
2024
Q3 | $206K | Hold |
12,500
| – | – | ﹤0.01% | 1551 |
|
|
2024
Q2 | $239K | Hold |
12,500
| – | – | ﹤0.01% | 1538 |
|
|
2024
Q1 | $335K | Hold |
12,500
| – | – | ﹤0.01% | 1480 |
|
|
2023
Q4 | $171K | Hold |
12,500
| – | – | ﹤0.01% | 1556 |
|
|
2023
Q3 | $194K | Hold |
12,500
| – | – | ﹤0.01% | 1529 |
|
|
2023
Q2 | $270K | Hold |
12,500
| – | – | ﹤0.01% | 1525 |
|
|
2023
Q1 | $222K | Hold |
12,500
| – | – | ﹤0.01% | 1545 |
|
|
2022
Q4 | $212K | Hold |
12,500
| – | – | ﹤0.01% | 1598 |
|
|
2022
Q3 | $413K | Hold |
12,500
| – | – | ﹤0.01% | 1550 |
|
|
2022
Q2 | $705K | Hold |
12,500
| – | – | ﹤0.01% | 1549 |
|
|
2022
Q1 | $729 | Sell |
12,500
-20
| -0.2% | -$1.25K | ﹤0.01% | 1601 |
|
|
2021
Q4 | $901K | Hold |
12,520
| – | – | ﹤0.01% | 1578 |
|
|
2021
Q3 | $1.01M | Hold |
12,520
| – | – | ﹤0.01% | 1582 |
|
|
2021
Q2 | $1.21M | Hold |
12,520
| – | – | ﹤0.01% | 1563 |
|
|
2021
Q1 | $1.5M | Sell |
12,520
-9
| -0.1% | -$1.3K | ﹤0.01% | 1287 |
|
|
2020
Q4 | $1.64M | Buy |
12,529
+4,166
| +50% | +$538K | ﹤0.01% | 1163 |
|
|
2020
Q3 | $883K | Hold |
8,363
| – | – | ﹤0.01% | 1263 |
|
|
2020
Q2 | $2.15M | Buy |
8,363
+30
| +0.4% | +$11.4K | ﹤0.01% | 989 |
|
|
2020
Q1 | $3.71M | Hold |
8,333
| – | – | 0.01% | 777 |
|
|
2019
Q4 | $5.63M | Buy |
+8,333
| New | +$4.18M | 0.01% | 782 |
|
Other funds holding NXTC
SI
AAA
P
CCC
CPA
